This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies

PUNE, INDIA, August 16, 2016 /EINPresswire.com/ -- Pancreatic Beta-Cell Protection

Description

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Diabetes Drug market. The report also provides strategic insights on medicines that are likely to have an impact on beta-cell protection treatment space and potentially alter standards of care in the foreseeable future.

Report Detail’s@ https://www.wiseguyreports.com/reports/605491-pancreatic-beta-cell-protection-hot-targets-pipeline-analysis


Therapies that are presently available for diabetes focus on reducing the disease symptoms, but there is a huge unmet need for therapies that can either slow or prevent the beta cell loss as there is a rapid loss of cells in type 1 diabetes and progressive loss in type 2 diabetes patients

Currently, researchers are focusing on novel therapeutic strategies aimed at restoring, or at least preventing further loss of beta cell mass in beta cell deficit type 1 and type 2 diabetes patients as endogenous secretion of insulin is advantageous over exogenous insulin such as direct effect on hepatic (liver) glucose metabolism. Hence, it provides a tremendous opportunity for upcoming therapies specific to Beta-cell loss such as MAbs, stem cell-based, gene therapies and RNA-based therapies. These modalities may provide beta-cell protection, regeneration, mass increase with additional benefits of weight loss, triglyceride lowering and kidney protection.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/605491-pancreatic-beta-cell-protection-hot-targets-pipeline-analysis



Table of Content

2 —INTRODUCTION-PANCREATIC BETA CELL PROTECTION

2.1 —Diabetes Snapshot & Prevalence

3 —RESEARCH METHODOLOGY

3.1 —Sources

4 —HOT TARGETS-BETA CELL PROTECTION

5 —TARGET ANALYSIS –

5.1 —Top Targets

5.2 —Top University/Company

6 —MOLECULES – BETA CELL PROTECTION

6.1 —Beta Cell Protection Pipeline By Molecule Type

6.2 —Small Molecules Segmentation By Phase

6.3 —Large Molecules Segmentation By Phase

6.4 —Beta Cell Protection Pipeline By Phases

6.5 —Beta Cell Protection Pipeline By Companies

6.6 —Beta cell Protection – Molecules Vs Targets

7 —OTHER TARGETS ON BETA CELL PROTECTION

8 —BETA CELL PROTECTION – DEALS

9 —TARGETS – BETA CELL APOPTOSIS

10 —OTHER TARGETS ON BETA CELL APOPTOSIS

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=605491

Continued...

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.